Market closed
Bolt Biotherapeutics/$BOLT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Bolt Biotherapeutics
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
Ticker
$BOLT
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
52
Website
BOLT Metrics
BasicAdvanced
$14M
-
-$1.65
0.94
-
Price and volume
Market cap
$14M
Beta
0.94
52-week high
$0.48
52-week low
$0.30
Average daily volume
136K
Financial strength
Current ratio
3.205
Quick ratio
3.035
Long term debt to equity
40.138
Total debt to equity
44.073
Management effectiveness
Return on assets (TTM)
-32.88%
Return on equity (TTM)
-74.28%
Valuation
Price to revenue (TTM)
1.837
Price to book
0.25
Price to tangible book (TTM)
0.25
Price to free cash flow (TTM)
-0.23
Growth
Revenue change (TTM)
-2.36%
Earnings per share change (TTM)
-9.67%
3-year revenue growth (CAGR)
82.75%
3-year earnings per share growth (CAGR)
-17.74%
BOLT News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Bolt Biotherapeutics stock?
Bolt Biotherapeutics (BOLT) has a market cap of $14M as of April 16, 2025.
What is the P/E ratio for Bolt Biotherapeutics stock?
The price to earnings (P/E) ratio for Bolt Biotherapeutics (BOLT) stock is 0 as of April 16, 2025.
Does Bolt Biotherapeutics stock pay dividends?
No, Bolt Biotherapeutics (BOLT) stock does not pay dividends to its shareholders as of April 16, 2025.
When is the next Bolt Biotherapeutics dividend payment date?
Bolt Biotherapeutics (BOLT) stock does not pay dividends to its shareholders.
What is the beta indicator for Bolt Biotherapeutics?
Bolt Biotherapeutics (BOLT) has a beta rating of 0.94. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.